Summary: Our objective was to evaluate the role of echoplanar diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) maps in the assessment of response of uterine fibroids and myometrium to uterine fibroid embolization (UFE). We evaluated 32 fibroids in 11 patients treated with UFE. Treated lesions had low ADC values compared to untreated lesions. Furthermore, ADC values of the myometrium did not significantly change after embolization, suggesting maintained myometrial viability after embolization. DWI and ADC maps, by providing functional information at a cellular level, may serve as imaging tools for assessing treatment response after UFE. D iffusion-weighted imaging (DWI) can provide an insight about water mobility within tissues, which is based on cellular permeability. 1 In the pelvis, a fast echo-planar MR imaging technique may be applied to assess diffusion parameters.
D
iffusion-weighted imaging (DWI) can provide an insight about water mobility within tissues, which is based on cellular permeability. 1 In the pelvis, a fast echo-planar MR imaging technique may be applied to assess diffusion parameters. 2 Uterine fibroid embolization (UFE) is an alternative to surgical treatment of uterine fibroids in which blood flow to these lesions is obliterated. 3 The purpose of this preliminary study was to evaluate the role of DWI in the assessing treatment response to UFE. Our hypothesis is that reduction or elimination of blood flow to successfully treated fibroids would lead to membranous destruction and cellular dehydration. Intact myometrial perfusion and viability would result in stability in water permeability.
MATERIALS AND METHODS

Patients Characteristics
We retrospectively reviewed our database of patients that underwent UFE in our institution between April 2002 and March 2003. Our inclusion criteria were the following: diagnosis of symptomatic uterine fibroids, treatment with UFE and DWI imaging prior to and following treatment. During the same period, 69 patients had UFE in our institution but were not included because they did not receive this specific MR imaging protocol, or their MR evaluation was performed in another institution. All patients that received a follow-up DWI within the study period were included, regardless of the time interval between imaging and treatment. Informed consent was obtained on all patients before UFE, and the study was performed according to our institutional review board guidelines.
MRI Technique
Patients were scanned using a 1.5-T MRI scanner (CV/i, General Electric Medical Systems, Milwaukee, WI), and a phased array surface coil. Imaging protocol consisted of T2-weighted fast spin-echo images (matrix size, 256 3 256; slice thickness, 8 mm; interslice gap, 2 mm; TR/TE, 5000/100; receive bandwidth, 32 kHz), and breath-hold unenhanced and contrast-enhanced (0.1 mmol/kg IV gadodiamide [Omniscan, Amersham Health, Princeton, NJ]) T1-weighted 3-dimensional fat-suppressed spoiled gradient-echo (matrix, 192 3 160; slice thickness, 4-6 mm; TE, 1.2; receive bandwidth, 64 kHz; flip angle, 15°) images in venous (60 seconds) phase.
Diffusion Weighted Imaging and B-Value Calculations
The DWI series were executed with breath holding to avoid respiratory motion. DWI was performed in the axial plane in combination with echoplanar imaging using the following parameters: TR range/TE, 5700/97.5; receive bandwidth, 62 kHz; matrix, 128 3 128; slice thickness, 6 mm; interslice gap, 1 mm. In this sequence, 90°and 180°radio-frequency pulse series were applied and 2-motion-proving gradient pulses were also applied before and after the 180°r adiofrequency pulse. Data were then collected using echoplanar readout. Fat suppression was added to the DWI to avoid chemical shift artifacts.
We calculated the ADC values using the following equation D = 2[ln (S 1 ) 2 ln (S 0 )]/(b 1 2 b 0 ), where b 0 = 0 seconds/mm 2 and S 0 is the signal intensity for this value and b 1 = 500 seconds/mm 2 and S 1 is the signal intensity for b 1 . 4 In this way, 2 signal acquisitions were obtained for each study. The first one, where the b 0 = 0 was prescribed, provides the S 0 signal intensity used in this equation, whereas the second signal acquisition uses the prescribed b-value of 500. The b-value of 500 was chosen based on optimum signal-to-noise ratio, as demonstrated in a previous study. 5 
Embolization Procedure
An experienced interventional radiologist performed all embolization procedures. A unilateral femoral access was achieved using a microcatheter and bilateral selective embolization of the uterine fibroids was performed using 500-900 mm tris-acryl gelatin microspheres (Embosphere Microspheres; Biosphere Medical, Rockland, MA). Adequate sluggish flow was achieved within the selected branches, but the main uterine arteries were left patent.
Image Analysis
Two experienced radiologists performed the image analysis by consensus. The readers were not blinded to the treatment status for each examination to ensure accurate localization of treated fibroids. Imaging variables assessed for each fibroid before and after UFE included the following: maximum diameter, location, signal intensity, homogeneity, and the degree of enhancement on the venous phase. The maximum diameter for each leiomyoma was measured in the axial plane on the T2 sequence. Fibroids were classified as submucosal, intramural, or subserosal. The signal intensity of the fibroid was evaluated subjectively on T1, T2, and DWI based on a 3-tier scale: hyperintense, hypointense, and isointense when compared with skeletal muscle. All fibroids greater than 2 cm, regardless of lesion homogeneity or signal intensity, were included in this study. Lesions ,2 cm were not included since they may not be detected on DWI. Up to 4 fibroids were included in each patient to ensure independent sampling. The degree of venous enhancement was based on a 5-point scale ranging from 0% to 100%.
Quantitative measurements of DWI were generated by tracing maps of the apparent diffusion coefficient (ADC) and using a commercially available Advantage Windows workstation (General Electric Medical Systems) for each fibroid, normal myometrium, and gluteus muscle. ADC values were recorded by placing a region of interest (ROI) over the treated mass, as seen on the axial image with the maximum lesion diameter, as well as in normal myometrium and gluteus muscle. Follow-up MR studies were evaluated in the same fashion, with baseline images available for comparison.
Statistical Analysis
Comparisons of imaging findings before and after UFE were performed with paired t tests. A P value of 0.05 or less was considered to indicate a significant difference.
Regression analysis was also performed to test for correlation between the degree of enhancement and the ADC values for all fibroids before and after embolization.
RESULTS
General Observations
We identified 11 premenopausal women (mean age, 41 years; range, 32-51 years) who underwent UFE and received DWI as part of their MRI protocol before and after treatment. We evaluated a total of 32 fibroids in the patients who fulfilled our inclusion criteria. These patients were treated with UFE within a mean period of 43 days (range: 1-153 days) after initial MR imaging. The mean interval between embolization and follow up MR imaging was 181 days (range: 99-239 days).
Morphologic Changes in Uterine Fibroids
On the pretreatment T1 sequence, 97% (31/32) of the lesions were isointense compared with muscle. On the posttreatment T1 sequence, 75% (24/32) of the lesions remained isointense, whereas 7 lesions (22%) had increased signal intensity compared with muscle. All of the lesions were hypointense on the pretreatment T2 sequence and remained hypointense after treatment. Mean lesion diameter before embolization was 5 cm (range 2-10 cm) and decreased to 4 cm (range 1-9 cm) after embolization (P = 0.018). Mean fibroid enhancement was 82% (range 10 to 100%) before embolization and decreased to 11% (range 0 to 40%) after embolization (P , 0.01) (Fig. 1) .
DWI
On pretreatment diffusion-weighted images, 84% (27/32) of the lesions had decreased signal compared with muscle. All of the fibroids that were evaluated had decreased signal on posttreatment diffusion-weighted images. (Fig. 2) . The ADC values for the myometrium and gluteal muscle did not significantly change after UFE (P . 0.1), compared with values that were obtained before treatment. Regression analysis to test for correlation between the measured ADC values and the percentage of enhancement for each fibroid showed that there was no correlation between the degree of enhancement and ADC values before embolization (r = 0.2, P = 0.96), whereas there was a positive correlation between the 2 values after embolization (r = 0.8, P , 0.0001).
DISCUSSION
The purpose of this study was to determine the changes in tissue diffusion properties of fibroids and the surrounding myometrium after UFE. According to these preliminary results, DWI and ADC maps may depict specific changes in water composition of uterine fibroids after embolization. Treated fibroids had low ADC values after treatment, compared with ADC values before treatment. ADC values for the myometrium remained stable, indicating specific treatment response.
MR imaging has been proven to be a useful modality in assessing response of fibroids to UFE. 6 However, current morphologic parameters used to assess treatment response, which are based on changes in fibroid size and enhancement, are not without limitations. Change in fibroid size or volume after treatment may not accurately predict lesion response, as embolization may be associated with hyalinizing necrosis without tissue collapse or decrease in tumor size. 7 Enhancing areas in a lesion are presumed to represent a viable component, likely due to collateral blood supply from the ovarian artery. However, residual enhancement may also result from postembolization inflammation. 8, 9 The ADC maps that are generated using DWI provide accurate quantification of the cellular motion of water molecules. 1, 4 Pathologic processes, such as benign or malignant lesions, may alter cellular structure and membranous permeability, with ultimate shifting of water molecules between tissue compartments. 4 The use of echo-planar imaging has expanded the initial application of DWI from the brain to the abdomen, and changes in ADC measurements of tissues or lesions may serve as a clinical follow-up tool after medical or locoregional therapy. 10 Postischemic cerebral changes have been reported to produce low ADC values. 11 Similar findings are reported in the current study, confirming infarction and dehydration of uterine fibroids after embolization. Before treatment, the accumulated clusters of uniform smooth muscle cells with intervening collagen within fibroids result in a restricted pattern of water diffusion. After therapy, the low signal intensity on DWI and the overall decrease of mean ADC values in these lesions advocate that there is increased dehydration at a cellular level. The mean ADC value of the myometrial tissue remained unchanged after embolization, confirming that there are minimal or no alterations in the myometrial cellular integrity. Similarly, the mean ADC value of the gluteus muscle did not change after treatment. Lack of change in myometrial ADC value after UFE is likely due to the 
